An article Structure-Based Design of a Potent and Selective Covalent Inhibitor for SRC Kinase That Targets a P-Loop Cysteine WOS:000517673100012 published article about CELL LUNG-CANCER; IRREVERSIBLE INHIBITORS; FAMILY KINASES; DISCOVERY; GROWTH; RESISTANCE; PROTEIN; OPTIMIZATION; ACTIVATION; EXPRESSION in [Gurbani, Deepak; Westover, Kenneth D.; Zhang, Tinghu] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Gurbani, Deepak; Westover, Kenneth D.; Zhang, Tinghu] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Du, Guangyan; Rao, Suman; Henning, Nathaniel J.; Jiang, Jie; Che, Jianwei; Ficarro, Scott B.; Marto, Jarrod A.; Westover, Kenneth D.; Zhang, Tinghu; Gray, Nathanael S.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Du, Guangyan; Rao, Suman; Henning, Nathaniel J.; Jiang, Jie; Che, Jianwei; Westover, Kenneth D.; Zhang, Tinghu; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Yang, Annan; Aguirre, Andrew J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Sorger, Peter K.] Harvard Med Sch, Lab Syst Biol, Boston, MA 02115 USA in 2020, Cited 51. The Name is 2-Chloro-6-methylaniline. Through research, I have a further understanding and discovery of 87-63-8. COA of Formula: C7H8ClN
SRC is a major regulator of many signaling pathways and contributes to cancer development. However, development of a selective SRC inhibitor has been challenging, and FDA-approved SRC inhibitors, dasatinib and bosutinib, are multitargeted kinase inhibitors. Here, we describe our efforts to develop a selective SRC covalent inhibitor by targeting cysteine 277 on the P-loop of SRC. Using a promiscuous covalent kinase inhibitor (CKI) SM1-71 as a starting point, we developed covalent inhibitor 15a, which discriminates SRC from other covalent targets of SM1-71 including TAK1 and FGFR1. As an irreversible covalent inhibitor, compound 15a exhibited sustained inhibition of SRC signaling both in vitro and in vivo. Moreover, 15a exhibited potent antiproliferative effects in nonsmall cell lung cancer cell lines harboring SRC activation, thus providing evidence that this approach may be promising for further drug development efforts.
About 2-Chloro-6-methylaniline, If you have any questions, you can contact Du, GY; Rao, SM; Gurbani, D; Henning, NJ; Jiang, J; Che, JW; Yang, A; Ficarro, SB; Marto, JA; Aguirre, AJ; Sorger, PK; Westover, KD; Zhang, TH; Gray, NS or concate me.. COA of Formula: C7H8ClN
Reference:
Patent; ASTRAZENECA AB; NPS PHARMACEUTICALS, INC.; WO2006/20879; (2006); A1;,
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics